ANDA 75924, held by Pharm Assoc. Doxepin Hydrochloride.
As of Nov 16, 2026, ANDA 75924 (Doxepin Hydrochloride), held by Pharm Assoc, was first approved by FDA on Jan 15, 2004, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 15, 2004 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxepin HydrochlorideEQ 10MG BASE/ML · concentrate;oral | Doxepin Hydrochloride | Discontinued |
| Sep 11, 2014 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jan 15, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters